Found: 39
Select item for more details and to access through your institution.
Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modernera therapy: A real-life study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1069360
- By:
- Publication type:
- Article
Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1103, doi. 10.1111/bjh.18772
- By:
- Publication type:
- Article
Inflammatory Waldenström's macroglobulinaemia: A French monocentric retrospective study of 67 patients.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 6, p. 728, doi. 10.1111/bjh.18157
- By:
- Publication type:
- Article
Multiple myeloma occurring in a case of Niemann‐Pick disease Type B: A pathophysiological link?
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 4, p. e53, doi. 10.1111/bjh.18050
- By:
- Publication type:
- Article
Thiotepa intrathecal injections for myelomatous central nervous system involvement.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. e9, doi. 10.1111/bjh.17343
- By:
- Publication type:
- Article
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. e73, doi. 10.1111/bjh.16483
- By:
- Publication type:
- Article
Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 2, p. 338, doi. 10.1111/bjh.16333
- By:
- Publication type:
- Article
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trial.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 319, doi. 10.1111/bjh.16059
- By:
- Publication type:
- Article
Ruxolitinib as a promising treatment for corticosteroid‐refractory graft‐versus‐host disease.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 687, doi. 10.1111/bjh.14679
- By:
- Publication type:
- Article
L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 4, p. 543, doi. 10.1111/bjh.12523
- By:
- Publication type:
- Article
A Combination of Cytokines Rescues Highly Purified Leukemic CLL B-Cells from Spontaneous Apoptosis <i>In Vitro</i>.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0060370
- By:
- Publication type:
- Article
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 231, doi. 10.1002/ejhf.2016
- By:
- Publication type:
- Article
Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma.
- Published in:
- Medical Sciences, 2023, v. 11, n. 1, p. 14, doi. 10.3390/medsci11010014
- By:
- Publication type:
- Article
A Prospective Phase II of Daratumumab in Previously Treated Systemic Light-Chain (AL) Amyloidosis: Updated Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e40, doi. 10.1016/j.clml.2019.09.061
- By:
- Publication type:
- Article
Correction to: A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.
- Published in:
- Journal of Clinical Immunology, 2019, v. 39, n. 7, p. 702, doi. 10.1007/s10875-019-00658-9
- By:
- Publication type:
- Article
Thromboembolism and bleeding in systemic amyloidosis: a review.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 1, p. 11, doi. 10.1002/ehf2.13701
- By:
- Publication type:
- Article
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00397-w
- By:
- Publication type:
- Article
Diagnostic score of cardiac involvement in AL amyloidosis.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2020, v. 21, n. 5, p. 542, doi. 10.1093/ehjci/jez180
- By:
- Publication type:
- Article
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. 1214, doi. 10.1002/ajh.25608
- By:
- Publication type:
- Article
Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. 635, doi. 10.1002/ajh.25459
- By:
- Publication type:
- Article
A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study).
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. 23, doi. 10.1002/ajh.24570
- By:
- Publication type:
- Article
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 366, doi. 10.1002/ajh.24278
- By:
- Publication type:
- Article
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 366, doi. 10.1002/ajh.24278
- By:
- Publication type:
- Article
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 3, p. 204, doi. 10.1002/ajh.23909
- By:
- Publication type:
- Article
5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 7, p. 601, doi. 10.1002/ajh.23464
- By:
- Publication type:
- Article
Efficacy of lenalidomide in POEMS syndrome: A retrospective study of 20 patients.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 207, doi. 10.1002/ajh.23374
- By:
- Publication type:
- Article
Patella plasmacytoma: An unusual localization.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 6, p. 504, doi. 10.1002/ajh.21961
- By:
- Publication type:
- Article
Recommandations 2024 de l'Intergroupe francophone du myélome sur la prise en charge des gammapathies monoclonales de signification indéterminée.
- Published in:
- Hematologie, 2024, v. 30, n. 1, p. 71, doi. 10.1684/hma.2024.1840
- By:
- Publication type:
- Article
Avoir un myélome avant 40 ans : une étude rétrospective francophone.
- Published in:
- Hematologie, 2021, v. 27, n. 6, p. 281, doi. 10.1684/hma.2021.1702
- By:
- Publication type:
- Article
Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.
- Published in:
- Immunology & Cell Biology, 2014, v. 92, n. 7, p. 591, doi. 10.1038/icb.2014.37
- By:
- Publication type:
- Article
CAR‐T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 970, doi. 10.1002/jha2.479
- By:
- Publication type:
- Article
Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.
- Published in:
- Journal of the Peripheral Nervous System, 2011, v. 16, n. 3, p. 180, doi. 10.1111/j.1529-8027.2011.00343.x
- By:
- Publication type:
- Article
TLR9 ligand (CpG oligodeoxynucleotide) induces CLL B-cells to differentiate into CD20<sup>+</sup> antibody-secreting cells.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00292
- By:
- Publication type:
- Article
Study of the B cell memory compartment in common variable immunodeficiency.
- Published in:
- European Journal of Immunology, 2000, v. 30, n. 9, p. 2516, doi. 10.1002/1521-4141(200009)30:9<2516::AID-IMMU2516>3.0.CO;2-Z
- By:
- Publication type:
- Article
CLINICAL NEPHROLOGY - EPIDEMIOLOGY - CLINICAL TRIALS High dose chemotherapy in light chain or light and heavy chain deposition disease.
- Published in:
- Kidney International, 2004, v. 65, n. 2, p. 642, doi. 10.1111/j.1523-1755.2004.00427.x
- By:
- Publication type:
- Article